Schedule 13G ownership disclosure

Keenova Therapeutics PLC

Ordinary Shares, par value $0.01 per share · CUSIP: G5890A102

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Mgmt, L.P.

    Shares: 804,258.00 · Class: 4.07%

  • Deerfield Mgmt IV, L.P.

    Shares: 1.00 · Class: 0%

  • Deerfield Partners, L.P.

    Shares: 804,258.00 · Class: 4.07%

  • Deerfield Private Design Fund IV, L.P.

    Shares: 1.00 · Class: 0%

  • Deerfield Management Company, L.P.

    Shares: 804,259.00 · Class: 4.07%

  • James E. Flynn

    Shares: 804,259.00 · Class: 4.07%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-000646
Form type
SCHEDULE 13G/A
Filer
Flynn James E
CIK
CIK 1352546
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub